Search

Carmen N Mak

from Westfield, NJ
Age ~55
Get Report
Also known as:
Carmen Mac, Claire Mak
Related to:
Meagan Lo, 25Madison J Lo, 23Jonathan Lo, 56Scott P Orr, 56Claire Mak, 56
Connected to:
Allan K Mak, 40Brandon P Mak, 29Cary C Mak, 80Cathie Q Mak, 47Chaimei C Mak, 59Cheen N Mak, 52Chiang W Mak, 64Chin Mak, 46Eugenia W Mak, 55Gene Mak, 45

Carmen Mak Phones & Addresses

  • Westfield, NJ
  • Portland, OR
  • 14 Jeffers Rd, Plainsboro, NJ 08536 (609) 716-0888
  • 123 Autumn Ridge Rd, Bedminster, NJ 07921 (908) 781-6727
  • New Brunswick, NJ
  • New York, NY

Resumes

Resumes

Carmen Mak Photo 1

Head Of Biometrics

View page
Location:
14800 Charlson Rd, Eden Prairie, MN 55347
Industry:
Pharmaceuticals
Work:
Merck Gsk Novartis Abbvie 2012 - 2019
Statistical Consultant
Merck Nov 2006 - 2011
Manager, Statistics
Novo Nordisk 2005 - 2006
Senior Statistician
Schering-Plough Research Institute 2000 - 2001
Senior Statistician
Schering-Plough Research Institute 1999 - 2000
Research Statistician
Education:
University of Toronto 1995 - 1998
Doctorates, Doctor of Philosophy, Statistics University of Waterloo 1987 - 1992
Bachelor of Mathematics, Bachelors, Statistics
Skills:
Clinical Development
Drug Development
Clinical Trials
Pharmaceutical Industry
Cro
Oncology
Biostatistics
Regulatory Submissions
Biotechnology
Clinical Research
Gcp
Infectious Diseases
Ctms
Clinical Data Management
Cro Management
Biomarkers
Cdisc
Carmen Mak Photo 2

Carmen Mak

View page
Carmen Mak Photo 3

Carmen Mak

View page
Carmen Mak Photo 4

Carmen Mak

View page
Carmen Mak Photo 5

Carmen Mak

View page

Publications

Us Patents

Dosages And Uses Of Ornithine Phenylacetate For Treating Hyperammonemia

View page
US Patent:
20220362192, Nov 17, 2022
Filed:
Oct 15, 2020
Appl. No.:
17/767009
Inventors:
- Hazelwood MO, US
- Bedminster NJ, US
Carmen Mak - Hampton NJ, US
Nagaraju Poola - Belle Mead NJ, US
Regis Vilchez - Chicago IL, US
Aniruddha Potnis - King of Prussia PA, US
Susan VanMeter - Ashburn VA, US
Jan Stange - San Diego CA, US
International Classification:
A61K 31/198
A61P 1/16
Abstract:
Embodiments of the present disclosure relate to doses of ornithine phenylacetate for treating or ameliorating hyperammonemia and the methods of administrating the same in a patient with a chronic liver disease, for example, cirrhosis. In some embodiments, the patient also has hepatic encephalopathy as a complication of the liver disease.
Control profile
Carmen N Mak from Westfield, NJ, age ~55 Get Report